Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation.
bladder cancer
immunohistochemistry
molecular classification
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
16 Jul 2022
16 Jul 2022
Historique:
received:
23
06
2022
revised:
09
07
2022
accepted:
12
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Following several attempts to achieve a molecular stratification of bladder cancer (BC) over the last decade, a "consensus" classification has been recently developed to provide a common base for the molecular classification of bladder cancer (BC), encompassing a six-cluster scheme with distinct prognostic and predictive characteristics. In order to implement molecular subtyping (MS) as a risk stratification tool in routine practice, immunohistochemistry (IHC) has been explored as a readily accessible, relatively inexpensive, standardized surrogate method, achieving promising results in different clinical settings. The second part of this review deals with the pathological and clinical features of the molecular clusters, both in conventional and divergent urothelial carcinoma, with a focus on the role of IHC-based subtyping.
Identifiants
pubmed: 35887192
pii: ijms23147844
doi: 10.3390/ijms23147844
pmc: PMC9317362
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Front Oncol. 2020 Feb 07;10:102
pubmed: 32117752
Cancer Immunol Res. 2019 Jun;7(6):923-938
pubmed: 30988029
Eur Urol. 2016 Oct;70(4):611-620
pubmed: 26988609
Eur Urol Oncol. 2020 Dec;3(6):728-738
pubmed: 33177001
Sci Transl Med. 2014 Jul 9;6(244):244ra91
pubmed: 25009231
Cancer Cell. 2016 Jul 11;30(1):27-42
pubmed: 27321955
Nature. 2018 Feb 22;554(7693):544-548
pubmed: 29443960
Urol Oncol. 2020 May;38(5):449-458
pubmed: 31740332
Virchows Arch. 2021 Sep;479(3):515-521
pubmed: 34218288
PLoS One. 2019 Aug 30;14(8):e0221785
pubmed: 31469885
Ann Diagn Pathol. 2019 Dec;43:151397
pubmed: 31494492
Cell. 2014 Aug 14;158(4):929-944
pubmed: 25109877
Bladder Cancer. 2016 Jan 7;2(1):37-47
pubmed: 27376123
Int J Mol Sci. 2020 Oct 19;21(20):
pubmed: 33086575
Virchows Arch. 2019 Oct;475(4):445-455
pubmed: 31240474
Lancet. 2016 May 7;387(10031):1909-20
pubmed: 26952546
Cancer Immunol Res. 2014 Sep;2(9):823-30
pubmed: 25187272
Oncotarget. 2018 May 25;9(40):25935-25945
pubmed: 29899832
Eur Urol. 2019 Mar;75(3):423-432
pubmed: 30213523
J Pathol. 2017 May;242(1):113-125
pubmed: 28195647
Lancet Oncol. 2017 Mar;18(3):312-322
pubmed: 28131785
Int J Mol Sci. 2019 Jan 29;20(3):
pubmed: 30699951
J Pathol Clin Res. 2022 Mar;8(2):143-154
pubmed: 34697907
Eur Urol. 2020 Oct;78(4):533-537
pubmed: 32684305
Virchows Arch. 2021 Apr;478(4):637-645
pubmed: 33128085
Virchows Arch. 2019 Sep;475(3):349-356
pubmed: 31300876
Am J Clin Pathol. 2017 May 01;147(5):500-506
pubmed: 28371875
Eur Urol. 2016 May;69(5):855-62
pubmed: 26343003
Pathol Int. 2014 Aug;64(8):375-81
pubmed: 25143125
J Immunoassay Immunochem. 2021 May 4;42(3):236-251
pubmed: 33213275
Virchows Arch. 2017 Sep;471(3):337-345
pubmed: 28721490
Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1408-1416
pubmed: 29960059
J Urol. 2013 May;189(5):1670-5
pubmed: 23142686
Eur Urol. 2015 Nov;68(5):824-32; discussion 835-6
pubmed: 25770486
Am J Pathol. 2020 Jan;190(1):134-144
pubmed: 31610173
Eur Urol. 2020 Apr;77(4):420-433
pubmed: 31563503
Clin Cancer Res. 2012 Jun 15;18(12):3377-86
pubmed: 22553347
Cancer Cell. 2014 Feb 10;25(2):152-65
pubmed: 24525232
Mod Pathol. 2002 Jan;15(1):6-10
pubmed: 11796835
Am J Surg Pathol. 2011 Apr;35(4):474-83
pubmed: 21383609
Pathol Int. 2021 Mar;71(3):173-182
pubmed: 33503295
J Clin Pathol. 2021 Jun 8;:
pubmed: 34103388
J Pathol. 2019 Apr;247(5):563-573
pubmed: 30604486
Lancet Oncol. 2016 Nov;17(11):1590-1598
pubmed: 27733243
Oncogene. 2018 May;37(22):3039-3044
pubmed: 29535424
Am J Pathol. 2013 Sep;183(3):681-91
pubmed: 23827819
PLoS One. 2017 Jun 20;12(6):e0179602
pubmed: 28632777
J Immunoassay Immunochem. 2021 Nov 2;42(6):662-678
pubmed: 34106817
Adv Anat Pathol. 2019 Jul;26(4):251-256
pubmed: 31188799
Histopathology. 2018 Nov;73(5):748-757
pubmed: 29947424
Eur Urol Oncol. 2019 Nov;2(6):625-642
pubmed: 31601522
Virchows Arch. 2017 Mar;470(3):267-274
pubmed: 28074276
Cancers (Basel). 2020 Mar 24;12(3):
pubmed: 32213857
J Urol. 2014 Jan;191(1):40-7
pubmed: 23911605
J Cell Physiol. 2007 Nov;213(2):374-83
pubmed: 17680632
Front Oncol. 2020 Dec 07;10:527385
pubmed: 33365265
Eur Urol. 2005 Apr;47(4):463-7
pubmed: 15774242
Cell Rep. 2019 May 7;27(6):1781-1793.e4
pubmed: 31067463
Ann Oncol. 2011 Aug;22(8):1736-47
pubmed: 21709140
Int J Mol Sci. 2018 Oct 30;19(11):
pubmed: 30380731
Cancer Res. 2010 May 1;70(9):3463-72
pubmed: 20406976
Virchows Arch. 2021 Aug;479(2):325-335
pubmed: 33650041
Nat Rev Clin Oncol. 2018 Apr;15(4):234-248
pubmed: 29405201
Cancer Rep (Hoboken). 2021 Apr;4(2):e1313
pubmed: 33538412
J Pathol. 2022 Jan;256(1):108-118
pubmed: 34611919
Hum Pathol. 2022 Apr;122:11-24
pubmed: 35108518
Ann Diagn Pathol. 2019 Oct;42:7-11
pubmed: 31302372
Investig Clin Urol. 2021 May;62(3):274-281
pubmed: 33943049
Nature. 2014 Mar 20;507(7492):315-22
pubmed: 24476821
Nat Rev Urol. 2014 Jul;11(7):400-10
pubmed: 24960601
Crit Rev Clin Lab Sci. 2015;52(5):242-55
pubmed: 26053693
Hum Pathol. 2019 Aug;90:27-36
pubmed: 31054897
Oncotarget. 2016 Nov 15;7(46):75176-75184
pubmed: 27750214
Eur Urol. 2020 Feb;77(2):223-250
pubmed: 31753752
Cell Death Differ. 2017 May;24(5):809-818
pubmed: 28282036
Oncology. 2021;99(6):345-358
pubmed: 33735905
Histopathology. 2019 Feb;74(3):483-493
pubmed: 30286252
Mol Clin Oncol. 2019 Feb;10(2):205-213
pubmed: 30680196
Int J Mol Sci. 2021 Jan 10;22(2):
pubmed: 33435173
Nat Genet. 2016 Apr;48(4):356-8
pubmed: 26901067
Sci Rep. 2020 Jun 16;10(1):9743
pubmed: 32546765
Ther Adv Urol. 2016 Jun;8(3):215-33
pubmed: 27247631
Eur Urol. 2017 Oct;72(4):544-554
pubmed: 28390739
Hum Pathol. 2018 Sep;79:57-65
pubmed: 29763719
Cell. 2017 Oct 19;171(3):540-556.e25
pubmed: 28988769
Stem Cells. 2009 Jul;27(7):1487-95
pubmed: 19544456
J Urol. 2017 Sep;198(3):552-559
pubmed: 28456635
Cell. 2009 Nov 25;139(5):871-90
pubmed: 19945376
Eur Urol. 2017 Sep;72(3):354-365
pubmed: 28365159
Arch Pathol Lab Med. 2019 Jun;143(6):695-704
pubmed: 30672335
Urol Int. 2019;102(3):249-261
pubmed: 30463072
Sci Rep. 2018 Feb 27;8(1):3737
pubmed: 29487377
Dis Markers. 2016;2016:5259602
pubmed: 27199504
Curr Mol Med. 2012 Jan;12(1):96-110
pubmed: 22082486
Cancer. 2017 Nov 15;123(22):4346-4355
pubmed: 28743155
Sci Rep. 2021 Oct 27;11(1):21186
pubmed: 34707176
Hum Pathol. 2014 Jul;45(7):1473-82
pubmed: 24780825
Transl Androl Urol. 2020 Dec;9(6):2881-2889
pubmed: 33457262
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14016-21
pubmed: 19666525
Eur Urol. 2019 Jan;75(1):18-22
pubmed: 30266310
Nat Commun. 2020 Sep 25;11(1):4858
pubmed: 32978382
Sci Rep. 2017 Sep 15;7(1):11702
pubmed: 28916750
EBioMedicine. 2016 Oct;12:105-117
pubmed: 27612592
Eur Urol. 2019 Jun;75(6):961-964
pubmed: 30851984
Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3110-5
pubmed: 24520177
Am J Surg Pathol. 2011 Sep;35(9):1337-42
pubmed: 21836490
Histopathology. 2017 Nov;71(5):703-710
pubmed: 28805264
Histopathology. 2019 Dec;75(6):865-875
pubmed: 31348552
World J Urol. 2019 Sep;37(9):1759-1765
pubmed: 30392011
Urol Oncol. 2022 Jan;40(1):12.e1-12.e11
pubmed: 34429252
Nat Rev Urol. 2020 Feb;17(2):69-70
pubmed: 31796938
World J Urol. 2021 Nov;39(11):4011-4019
pubmed: 34259899
Clin Cancer Res. 2019 Aug 15;25(16):5082-5093
pubmed: 30224344
Anticancer Res. 2020 May;40(5):2439-2447
pubmed: 32366387
Mod Pathol. 2013 May;26(5):725-32
pubmed: 23348900
Cells. 2020 Jan 25;9(2):
pubmed: 31991796
Sci Rep. 2016 Dec 07;6:38531
pubmed: 27924948
Crit Rev Clin Lab Sci. 2014 Oct;51(5):291-304
pubmed: 25036341
Clinics (Sao Paulo). 2021 Apr 26;76:e2587
pubmed: 33909826
Mod Pathol. 2020 Jun;33(6):1165-1171
pubmed: 31932679
Am J Clin Pathol. 2021 Mar 15;155(4):588-596
pubmed: 33118597
J Urol. 2013 May;189(5):1656-61
pubmed: 23159581
JCI Insight. 2016 Mar 17;1(3):e85902
pubmed: 27699256
Cancers (Basel). 2020 Jul 03;12(7):
pubmed: 32635360